These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28548552)

  • 41. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy.
    Plöhn S; Edelmann B; Japtok L; He X; Hose M; Hansen W; Schuchman EH; Eckstein A; Berchner-Pfannschmidt U
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5391-5397. PubMed ID: 30452592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor β1 (TGFβ1) and vascular endothelial growth factor (VEGF) in the blood of healthy people and patients with Graves' orbitopathy--a new mechanism of glucocorticoids action?
    Kajdaniuk D; Marek B; Niedziołka-Zielonka D; Foltyn W; Nowak M; Siemińska L; Borgiel-Marek H; Głogowska-Szeląg J; Ostrowska Z; Drożdż L; Kos-Kudła B
    Endokrynol Pol; 2014; 65(5):348-56. PubMed ID: 25301484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.
    Wei H; Guan M; Qin Y; Xie C; Fu X; Gao F; Xue Y
    Endocr J; 2014; 61(11):1087-92. PubMed ID: 25100151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy.
    Mou P; Chen Z; Jiang L; Cheng J; Wei R
    Biomed Res Int; 2018; 2018():5961974. PubMed ID: 29675428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A genome-wide DNA methylation analysis in peripheral blood from patients identifies risk loci associated with Graves' orbitopathy.
    Xin Z; Hua L; Shi TT; Tuo X; Yang FY; Li Y; Cao X; Yang JK
    J Endocrinol Invest; 2018 Jun; 41(6):719-727. PubMed ID: 29190000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysosome-related genes are regulated in the orbital fat of patients with graves' ophthalmopathy.
    Chen MH; Liao SL; Chen MH; Tsou PL; Shih MJ; Chang TC; Chuang LM
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4760-4. PubMed ID: 18552385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
    Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
    J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity.
    Slowik M; Urbaniak-Kujda D; Bohdanowicz-Pawlak A; Kapelko-Slowik K; Dybko J; Wolowiec D; Jazwiec B; Daroszewski J
    Endocr Res; 2012; 37(2):89-95. PubMed ID: 22489922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgG4 as a Biomarker in Graves' Orbitopathy.
    Olejarz M; Szczepanek-Parulska E; Dadej D; Sawicka-Gutaj N; Domin R; Ruchała M
    Mediators Inflamm; 2021; 2021():5590471. PubMed ID: 34220335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitive Blood-Based Detection of Asbestos-Associated Diseases Using Cysteine-Rich Angiogenic Inducer 61 as Circulating Protein Biomarker.
    Bartkowiak K; Casjens S; Andreas A; Ačkar L; Joosse SA; Raiko I; Brüning T; Geffken M; Peine S; Johnen G; Weber DG; Pantel K
    Clin Chem; 2021 Jan; 67(2):363-373. PubMed ID: 33336248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K
    Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis.
    Fan Y; Yang X; Zhao J; Sun X; Xie W; Huang Y; Li G; Hao Y; Zhang Z
    Arthritis Res Ther; 2019 May; 21(1):123. PubMed ID: 31113467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
    Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
    J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.
    Planck T; Shahida B; Parikh H; Ström K; Åsman P; Brorson H; Hallengren B; Lantz M
    Thyroid; 2014 Oct; 24(10):1524-32. PubMed ID: 25135760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy.
    Bozkirli E; Bakiner OS; Ersozlu Bozkirli ED; Eksi Haydardedeoglu F; Sizmaz S; Torun AI; Ertorer ME
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):962-7. PubMed ID: 25400133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between serum adipocytokines and Graves' ophthalmopathy: A hospital-based study.
    Kim BY; Mok JO; Kang SK; Jang SY; Jung CH; Kim CH
    Endocr J; 2016 May; 63(5):425-30. PubMed ID: 26842711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
    Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.